Trials / Unknown
UnknownNCT02293759
Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
Prospective Non-randomized Trial Comparing Holmium Laser Enucleation of the Prostate Versus Greenlight Laser Photoselective Vaporization of the Prostate in Treating Benign Prostate Hyperplasia in Patients With Bleeding Tendency
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile. Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP
Detailed description
Elderly patients with bleeding tendency either secondary; 1. Strict antiplatelet intake 2. Strict anticoagulant intake 3. uncorrected natural bleeding tendency e.g; patients with liver cell failure are at higher risk of perioperative bleeding when subjected to prostate surgery. Laser prostate surery was introduced to overcome this difficulty. However, till now there is no head to head comparision of different types of laser procedures in treating this subset of patients In the current study patients presented for BPH surgery in a tertiarry referral prostate unit will be assessed for bleeding tendency and will be treated either by Holmium laser enucleatiuon of the prostate or Greenlight laser vaporization of the prostate Single surgeon will perform all cases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | HoLEP | Holmium laser enucleation of the prsotate |
| PROCEDURE | Greenlight laser PVP | Greenlight laser (532nm) Photoslective vaporization of the prostate |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-08-01
- Completion
- 2016-09-01
- First posted
- 2014-11-18
- Last updated
- 2016-03-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02293759. Inclusion in this directory is not an endorsement.